Alzheimer's drug that can slow disease gets backing from FDA advisers

WASHINGTON — A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with

Related Keywords

Japan ,Washington ,United States ,Japanese ,Thomas Montine ,Tanya Simuni ,Eli Lilly ,Drug Administration ,Stanford University ,National Institutes Of Health ,Northwestern University ,Dean Follmann ,National Institutes ,